{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:05:35Z","timestamp":1792296335189,"version":"4.4.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30MH062261"],"award-info":[{"award-number":["5P30MH062261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Inflammatory bowel disease (IBD) represents multifactorial chronic inflammatory conditions in the gastrointestinal tract and includes Crohn's disease (CD) and ulcerative colitis (UC). Despite similarities in pathobiology and disease symptoms, UC and CD represent distinct diseases and exhibit diverse therapeutic responses. While studies have now confirmed that IBD is associated with dramatic changes in the gut microbiota, specific changes in the gut microbiome and associated metabolic effects on the host due to CD and UC are less well-understood.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To address this knowledge gap, we performed an extensive unbiased meta-analysis of the gut microbiome data from five different IBD patient cohorts from five different countries using QIIME2, DIAMOND, and STAMP bioinformatics platforms. <jats:italic>In-silico<\/jats:italic> profiling of the metabolic pathways and community metabolic modeling were carried out to identify disease-specific association of the metabolic fluxes and signaling pathways.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our results demonstrated a highly conserved gut microbiota community between healthy individuals and IBD patients at higher phylogenetic levels. However, at or below the order level in the taxonomic rank, we found significant disease-specific alterations. Similarly, we identified differential enrichment of the metabolic pathways in CD and UC, which included enriched pathways related to amino acid and glycan biosynthesis and metabolism, in addition to other metabolic pathways.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In conclusion, this study highlights the prospects of harnessing the gut microbiota to improve understanding of the etiology of CD and UC and to develop novel prognostic, and therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fmed.2020.606298","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T07:10:58Z","timestamp":1606461058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":105,"title":["Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Jagadesan","family":"Sankarasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagavardhini","family":"Avuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar B.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittibabu","family":"Guda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9170162","DOI":"10.1155\/2016\/9170162","article-title":"Colonic mucosal epigenome and microbiome development in children and adolescents","volume":"2016","author":"Harris","year":"2016","journal-title":"J. Immunol. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn's disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn's disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe."},{"key":"B9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40168-018-0603-4","article-title":"A comparative study of the gut microbiota in immune-mediated inflammatory diseases - does a common dysbiosis exist?","volume":"6","author":"Forbes","year":"2018","journal-title":"Microbiome."},{"key":"B11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","article-title":"A microbial signature for Crohn's disease","volume":"66","author":"Pascal","year":"2017","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature."},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell."},{"key":"B14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ismej.2011.139","article-title":"An improved greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea","volume":"6","author":"McDonald","year":"2012","journal-title":"ISME J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","article-title":"Fast and sensitive protein alignment using DIAMOND","volume":"12","author":"Buchfink","year":"2014","journal-title":"Nat. Methods."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1004957","DOI":"10.1371\/journal.pcbi.1004957","article-title":"MEGAN community edition - Interactive exploration and analysis of large-scale microbiome sequencing data","volume":"12","author":"Huson","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"B18","first-page":"1","article-title":"Package vegan: community ecology package","volume":"2","author":"Oksanen","year":"2013"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinformatics."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e39107","DOI":"10.1371\/journal.pone.0039107","article-title":"Gegenees: fragmented alignment of multiple genomes for determining phylogenomic distances and genetic signatures unique for specified target groups","volume":"7","author":"\u00c5gren","year":"2012","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13950","DOI":"10.1073\/pnas.0506758102","article-title":"Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial \u201cpan-genome.\u201d","volume":"102","author":"Tettelin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nbt.4163","article-title":"KBase: the United States department of energy systems biology knowledgebase","volume":"36","author":"Arkin","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","article-title":"A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients","volume":"9","author":"Hall","year":"2017","journal-title":"Genome Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","article-title":"Dynamics of metatranscription in the inflammatory bowel disease gut microbiome","volume":"3","author":"Schirmer","year":"2018","journal-title":"Nat. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12088-017-0652-6","article-title":"Targeted metagenome based analyses show gut microbial diversity of inflammatory bowel disease patients","volume":"57","author":"Qiu","year":"2017","journal-title":"Indian J. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2009.04.001","article-title":"Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis","volume":"137","author":"Gradel","year":"2009","journal-title":"Gastroenterology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1128\/JCM.42.3.1129-1135.2004","article-title":"Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis","volume":"42","author":"Bernstein","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ibd.20089","article-title":"Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease","volume":"13","author":"Bernstein","year":"2007","journal-title":"Inflamm. Bowel. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.gtc.2009.07.003","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"38","author":"Ananthakrishnan","year":"2009","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"B31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41598-018-37143-z","article-title":"The gut microbiota heterogeneity and assembly changes associated with the IBD","volume":"9","author":"Sun","year":"2019","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ibd.20392","article-title":"Analysis of bacterial bowel communities of IBD patients: what has it revealed?","volume":"14","author":"Sokol","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e26284","DOI":"10.1371\/journal.pone.0026284","article-title":"Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MOG.0b013e328339536b","article-title":"The intestinal microbiota in inflammatory bowel diseases: time to connect with the host","volume":"26","author":"Sokol","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3748\/wjg.v25.i18.2204","article-title":"Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease","volume":"25","author":"He","year":"2019","journal-title":"World J. Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1111\/1462-2920.12173","article-title":"A genomic update on clostridial phylogeny: gram-negative spore formers and other misplaced clostridia","volume":"15","author":"Yutin","year":"2013","journal-title":"Environ. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3389\/fmicb.2017.01226","article-title":"Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: a step forward in the use of F. prausnitzii as a next-generation probiotic","volume":"8","author":"Mart\u00edn","year":"2017","journal-title":"Front Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","article-title":"Alterations in lipid, amino acid, and energy metabolism distinguish Crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling","volume":"14","author":"Scoville","year":"2018","journal-title":"Metabolomics."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/1751-2980.12795","article-title":"Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease","volume":"20","author":"Weng","year":"2019","journal-title":"J. Dig. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","article-title":"Regulation of pyruvate metabolism and human disease","volume":"71","author":"Gray","year":"2014","journal-title":"Cell Mol. Life Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.606298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T07:11:02Z","timestamp":1606461062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.606298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":43,"alternative-id":["10.3389\/fmed.2020.606298"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.606298","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"article-number":"606298"}}